Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Treu Jesse I
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   55,258    

Indirect Shares

   2,983,502      
Direct Value   $34,611    

Indirect Value

   $10,596,677      
Total Shares   3,038,760      
Total Value   $10,631,289      


Northstar Neuroscience Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $80 Veracyte, Inc. $34,531 Northstar Neuroscience Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $80 Veracyte, Inc. $34,531
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director 2010-06-09 0 2009-12-18 0    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR Director 2007-05-18 17,231 2007-05-18 14,690    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 21,289 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 15,096 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA Director, 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT Director 2019-03-04 1,642 2019-03-04 1,641    Premium*  
            Tandem Diabetes Care Inc TNDM Director, 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX Director 2019-03-26 0 2019-03-26 8,763    Premium*  
* Premium Members only  

Records found :    157         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2010-08-20 3 IO $0.00 $0 I/I 0 8,032,129 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2010-10-06 4 A $0.00 $0 I/I 25,000 25,000 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2012-05-31 4 A $0.00 $0 I/I 93,434 93,434 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2012-05-31 4 D $0.00 $0 I/I (1,200,000) 6,772,968 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 A $0.00 $0 I/I 66,462 159,896 0 -
ACHN Achillion Pharmaceuticals... 10% Owner   –       –       •   2013-01-18 4 D $0.00 $0 I/I (1,000,000) 5,772,968 0 -
AKAO Achaogen Inc 10% Owner   –       –       •   2014-03-17 4 A $0.00 $0 I/I 2,020,939 33,890 0 -
ALDX Aldeyra Therapeutics, Inc... Director   –       •      –    2019-03-26 4 S $10.01 $968,397 I/I (96,743) 8,763 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 B $11.00 $4,158,308 I/I 378,028 4,829,773 1.5 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 A $0.00 $0 I/I 4,499,449 47,704 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 S $8.04 $55,589 I/I (6,914) 40,790 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 A $0.00 $0 I/I 18,864 18,864 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2011-06-02 4 D $0.00 $0 I/I (700,000) 4,129,773 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2006-10-24 3 IO $0.00 $0 I/I 0 27,500 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2006-10-30 4 A $0.00 $0 I/I 5,713,622 60,584 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2008-02-20 4 A $5.34 $14,999,996 I/I 2,808,988 90,369 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2009-02-18 4 B $7.13 $19,826,206 I/I 2,780,674 46,634 1.5 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2014-03-19 4 D $14.00 $146,195,434 I/I (10,442,531) 0 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2011-11-21 4 B $13.00 $12,111,879 I/I 931,683 51,013 1.5 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2011-11-21 4 A $0.00 $0 I/I 2,110,267 35,388 0 -
DRNA Dicerna Pharmaceuticals I... 10% Owner   –       –       •   2014-02-04 4 A $0.00 $0 I/I 1,765,711 13,004 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-18 3 IO $0.00 $0 I/I 0 6,250 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 B $9.00 $7,058,817 I/I 784,313 22,306 1.5 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 A $0.00 $0 I/I 2,244,125 16,529 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-06-25 3 IO $0.00 $0 I/I 0 21,471 -
  157  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us